Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease. [electronic resource]
Producer: 20020328Description: 634-8 p. digitalISSN:- 1524-4563
- Adult
- Aged
- Angiotensin-Converting Enzyme Inhibitors -- pharmacology
- Angiotensins -- blood
- Autoradiography
- Coronary Disease -- enzymology
- Endothelium, Vascular -- drug effects
- Female
- Gene Expression -- drug effects
- Humans
- Immunohistochemistry
- Male
- Middle Aged
- Nitric Oxide Synthase -- biosynthesis
- Nitric Oxide Synthase Type II
- Nitric Oxide Synthase Type III
- Peptidyl-Dipeptidase A -- biosynthesis
- Perindopril -- pharmacology
- Receptor, Angiotensin, Type 1
- Receptor, Angiotensin, Type 2
- Receptors, Angiotensin -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.